Cointime

Neoclone

company

About

Neoclone is a research-focused company with an emphasis on emerging antibody technologies.

  • 11 - 50

Highlights

Total Funding Amount
$1.03M
Funding Rounds
2
Investors
1
Investments
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$286.36K
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Active

Neoclone is a research-focused company with an emphasis on emerging antibody technologies. NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.03M
Neoclone has raised a total of $1.03M in funding over 2 rounds. Their latest funding was raised on Nov 1, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 1, 2012 Grant $286.36K 1 National Institutes of Health — Detail
Jun 7, 2007 Grant $750K 1 National Institutes of Health — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Neoclone has made 1 investments. Their most recent investment was on Aug 22, 2013, when Tyba raised $1.31M.
Date Company Name
Round Money Raised Industry Lead Investor
Aug 22, 2013 Tyba
Seed $1.31M Career Planning —

Investors

Number of Lead Investors
Number of Investors
2
1
Neoclone is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
İçerikler
Şirket.